Kestra Medical Technologies Ltd(KMTS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:48 PM ET (Korea 9/12 08:48)
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -2.42 | Insider Own | 59.17% | Shs Outstand | 58.4M | Perf Week | -9.11% |
| Market Cap | 1.34B | Forward P/E | - | EPS next Y | 10.3% | Insider Trans | -0.87% | Shs Float | 23.9M | Perf Month | -18.39% |
| Enterprise Value | 1.19B | PEG | - | EPS next Q | -0.62 | Inst Own | 47.2% | Short Float | 12.42% | Perf Quarter | 13.46% |
| Income | -0.13B | P/S | 14.08 | EPS this Y | 5.18% | Inst Trans | 0.52% | Short Ratio | 8.29 | Perf Half Y | 20.14% |
| Sales | 0.10B | P/B | 5.14 | EPS next 5Y | 9.74% | ROA | -40.24% | Short Interest | 2.97M | Perf YTD | -13.84% |
| Book/sh | 4.45 | P/C | 6.82 | EPS past 3/5Y | -11.52% - | ROE | -56.6% | 52W High | -23.83% ($30.00) | Perf Year | 24.18% |
| Cash/sh | 3.35 | P/FCF | - | Sales past 3/5Y | 131.88% - | ROIC | -42.95% | 52W Low | 31.78% ($17.34) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 2.13% | Gross Margin | 51.37% | Volatility(W/M) | 4.86% 4.58% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 12.5 | Sales Y/Y TTM | 59.03% | Oper. Margin | -141.65% | ATR (14) | 1.32 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.28 | EPS Q/Q | 37.23% | Profit Margin | -138.36% | RSI (14) | 32.78 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.41 | Sales Q/Q | 66.18% | SMA20 | -12.32% ($26.06) | Beta | 0.73 | Target Price | $30 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2026/9/14 | SMA50 | -9.92% ($25.37) | Rel Volume | 0.67 | Prev Close | $23.57 |
| Employees | 443 | LT Debt/Eq | 0.18 | EPS/Sales Surpr. | -13.56% 8.15% | SMA200 | -2.98% ($23.55) | Avg Volume(3M) | 0.36M | Price | $22.85 |
| IPO | 2025/3/6 | Option/Short | No/Yes | Trades | 4821 | Volume | 241,574 | Change | -3.05% |
Company
KMTS is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🫀 Kestra Medical Technologies (KMTS) is a US-listed medical device company centered on wearable cardiac defibrillators. Through its ASSURE wearable defibrillator and cardiac recovery system platform for patients at high risk of sudden cardiac arrest, it delivers an integrated offering that spans monitoring, therapy, digital health, and patient support. With a rental-based, recurring revenue model, the company is a growth-oriented medical device business rapidly expanding its market share.
Over the past 1 year, roughly in the middle
24% below its 1-year high.
Upcoming eventsD-$ until next earnings
Scheduled for September 14
KMTS has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +5.2% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 47.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
XHE 0.01%
FMED 0.01%
HEAL 0.01%
CBOT 0.00%
LYTE 0.00%It ranks #4 in the industry
Based on market cap of $1B.
KMTS $1B PER -
ISRG $131B PER 42.4
BDX $48B PER 53.6
MDLN $43B PER 38.1
FAQ
What kind of company is KMTS?
KMTS belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of KMTS?
The market cap of KMTS is approximately $1.3B, ranking 2,419 within its sector.
What is the 52-week high and low for KMTS?
KMTS has recorded a 52-week high of $30.00 and a low of $17.34.
